Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression.
Alonso R, Griebel G, Pavone G, Stemmelin J, Le Fur G, Soubrié P. Alonso R, et al. Among authors: griebel g. Mol Psychiatry. 2004 Mar;9(3):278-86, 224. doi: 10.1038/sj.mp.4001464. Mol Psychiatry. 2004. PMID: 14699428
The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G, Beeské S, Stahl SM. Griebel G, et al. J Clin Psychiatry. 2012 Nov;73(11):1403-11. doi: 10.4088/JCP.12m07804. Epub 2012 Oct 16. J Clin Psychiatry. 2012. PMID: 23146246
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, Hen R, Belzung C. Surget A, et al. Among authors: griebel g. Biol Psychiatry. 2008 Aug 15;64(4):293-301. doi: 10.1016/j.biopsych.2008.02.022. Epub 2008 Apr 11. Biol Psychiatry. 2008. PMID: 18406399
Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.
Dournes C, Beeské S, Belzung C, Griebel G. Dournes C, et al. Among authors: griebel g. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:213-20. doi: 10.1016/j.pnpbp.2012.07.019. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23367508
The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
Urani A, Philbert J, Cohen C, Griebel G. Urani A, et al. Among authors: griebel g. Pharmacol Biochem Behav. 2011 May;98(3):425-31. doi: 10.1016/j.pbb.2011.02.019. Epub 2011 Feb 26. Pharmacol Biochem Behav. 2011. PMID: 21356230
The neurokinin NK2 antagonist, saredutant, ameliorates stress-induced conditions without impairing cognition.
Rogacki N, Lopez-Grancha M, Naimoli V, Potestio L, Stevens RJ, Pichat P, Bergis OE, Cohen C, Varty GB, Griebel G. Rogacki N, et al. Among authors: griebel g. Pharmacol Biochem Behav. 2011 May;98(3):405-11. doi: 10.1016/j.pbb.2010.11.017. Epub 2010 Nov 27. Pharmacol Biochem Behav. 2011. PMID: 21115031
Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress.
Stemmelin J, Cohen C, Yalcin I, Keane P, Griebel G. Stemmelin J, et al. Among authors: griebel g. Behav Brain Res. 2010 Jan 20;206(2):310-2. doi: 10.1016/j.bbr.2009.09.003. Epub 2009 Sep 8. Behav Brain Res. 2010. PMID: 19744528
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vigé X, Biton B, Steinberg R, Françon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrié P, Scatton B. Depoortère R, et al. Among authors: griebel g. Neuropsychopharmacology. 2005 Nov;30(11):1963-85. doi: 10.1038/sj.npp.1300772. Neuropsychopharmacology. 2005. PMID: 15956994
Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal.
Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G, Belzung C, Sibille E. Surget A, et al. Among authors: griebel g. Neuropsychopharmacology. 2009 May;34(6):1363-80. doi: 10.1038/npp.2008.76. Epub 2008 Jun 4. Neuropsychopharmacology. 2009. PMID: 18536703 Free PMC article.
Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.
Ducottet C, Griebel G, Belzung C. Ducottet C, et al. Among authors: griebel g. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):625-31. doi: 10.1016/S0278-5846(03)00051-4. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12787849
139 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback